Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To investigate the role of postoperative nausea and vomiting risk factors assessment after
cardiac surgery. We designed a randomized controlled study comparing standard care (no risk
factor assessment and no intervention) with prophylaxis of postoperative nausea and vomiting
after cardiac surgery in high risk patients. Prophylaxis of postoperative nausea and vomiting
by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery,
depending on risk factors (if risk score is over 2) in the intervention arm.